PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biomedical Research Center, QU Health, Qatar University, 2713, Doha, Qatar. gheyath.nasrallah@qu.edu.qa.\', \'Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Women\'s Science building, C01, P.O Box: 2713, Doha, Qatar. gheyath.nasrallah@qu.edu.qa.\', \'Infectious Disease Epidemiology Group, Weill Cornell Medicine - Qatar, Qatar Foundation - Education City, Cornell University, P.O. Box 24144, Doha, Qatar.\', \'World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine - Qatar, Qatar Foundation - Education City, Cornell University, Doha, Qatar.\', \'Biomedical Research Center, QU Health, Qatar University, 2713, Doha, Qatar.\', \'Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Women\'s Science building, C01, P.O Box: 2713, Doha, Qatar.\', \'Hamad Medical Corporation, Doha, Qatar.\', \'College of Health Sciences, QU Health, Qatar University, Doha, Qatar.\', \'Primary Health Care Corporation, Doha, Qatar.\', \'Ministry of Public Health, Doha, Qatar.\', \'Department of Pathology, Sidra Medicine, Doha, Qatar.\', \'Infectious Disease Epidemiology Group, Weill Cornell Medicine - Qatar, Qatar Foundation - Education City, Cornell University, P.O. Box 24144, Doha, Qatar. lja2002@qatar-med.cornell.edu.\', \'World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine - Qatar, Qatar Foundation - Education City, Cornell University, Doha, Qatar. lja2002@qatar-med.cornell.edu.\', \'Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, USA. lja2002@qatar-med.cornell.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-91235-x
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34088944
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34088944>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34088944>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all